Learn more

SIGNATURE THERAPEUTICS INC

Overview
  • Total Patents
    65
  • GoodIP Patent Rank
    111,148
About

SIGNATURE THERAPEUTICS INC has a total of 65 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are RATIOPHARM GMBH, HUAIAN ANLAI BIOTECHNOLOGY CO LTD and 3B PHARMACEUTICALS GMBH.

Patent filings per year

Chart showing SIGNATURE THERAPEUTICS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Jenkins Thomas E 49
#2 Husfeld Craig O 37
#3 Seroogy Julie D 23
#4 Wray Jonathan W 23
#5 Thomas E Jenkins 9
#6 Craig O Husfeld 8
#7 Kolesnikov Aleksandr 6
#8 Jonathan W Wray 6
#9 Julie D Seroogy 5
#10 Jenkins Thomas 1

Latest patents

Publication Filing date Title
JP2015199772A Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof
AU2015201341A1 Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof
AU2013202270A1 Controlled release of phenolic opioids
CN103813800A Active agent prodrugs with heterocyclic linkers
WO2012122420A2 Opioid prodrugs with heterocyclic linkers
CN103384472A Compositions comprising enzyme-cleavable oxycodone prodrug
WO2012096886A1 Compositions comprising enzyme-cleavable oxycodone prodrug
EP2560486A1 Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof
EP2560491A1 Peripheral opioid agonists and peripheral opioid antagonists
EP2560490A1 Compositions comprising enzyme-cleavable prodrugs of active agents and inhibitors thereof
AU2010293028A1 Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof
EP2560489A1 Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof
AU2007267510A1 Controlled release of phenolic opioids